NOTV Stock Analysis: Buy, Sell, or Hold?
NOTV - Inotiv, Inc. Common Stock
$0.08
-0.02 (-15.89%)
▼
5d:
-33.25%
30d:
-72.79%
90d:
-79.52%
WAIT
LOW Confidence
Analysis Updated: Jun 10, 2026 12:00 AM ET
Earnings: Aug 05, 2026
TODAY
Get Alerted When NOTV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NOTV is down 33.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NOTV is down 33.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NOTV is currently trading at $0.08, which is considered fair based on recent price action.
Technical Outlook: Technically, NOTV is in a downtrend. The price is currently testing key support at $0.08. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 15.9% recently.
Market Sentiment: NOTV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.25 (+3967.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NOTV is in a downtrend. The price is currently testing key support at $0.08. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 15.9% recently.
Market Sentiment: NOTV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.25 (+3967.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
53/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
39.5%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BEARISH: Downward momentum (-15.9%)
- BULLISH: Trading 3967.6% below Wall St target ($3.25)
Support & Resistance Levels
Support Level
$0.08
Resistance Level
$0.32
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.04
Wall Street Target
$3.25
(+3967.6%)
Revenue Growth (YoY)
-5.4%
Profit Margin
-17.1%
Share & Embed Analysis
Last updated: August 03, 2026 10:55 PM ET
Data refreshes hourly during market hours. Next update: 11:55 PM
Data refreshes hourly during market hours. Next update: 11:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NOTV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Beth A Taylor
SELL
2888 shares
2026-02-17
John E Sagartz
SELL
2119 shares
2026-02-17
Robert Jr. Leasure
SELL
16810 shares
2026-02-17
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$630 | 53 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$188 | 61 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$283 | 59 HOLD |
